{
  "title": "Paper_207",
  "abstract": "ACS Infect Dis ACS Infect Dis 319 nihpa ACS infectious diseases 2373-8227 pmc-is-collection-domain yes pmc-collection-title NIHPA Author Manuscripts PMC12490196 PMC12490196.1 12490196 12490196 NIHMS2111021 40731254 10.1021/acsinfecdis.5c00296 NIHMS2111021 NIHPA2111021 1 Article GaSal-2: A Water-Soluble Antipseudomonal Agent Targeting the Extracellular Hemophore HasAp http://orcid.org/0000-0002-2427-8598 Frank Aziza Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States Hwang Lucia Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States Witt William T. West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States Centola Garrick Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States Johnson Kieran Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States http://orcid.org/0000-0002-7598-7992 Ai Yong Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States Sen-Kilic Emel West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States Pyles Gage M. West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States Huckaby Annalisa B. West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States Blackwood Catherine B. West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States Miller Sarah Jo West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States Hudson S. Matthew West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States Hom Kellie Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States http://orcid.org/0000-0001-6962-5314 Yu Wenbo Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States; United States http://orcid.org/0000-0001-8287-6804 MacKerell Alexander D. Jr. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States; United States http://orcid.org/0000-0002-3250-3636 Barbier Mariette West Virginia University Vaccine Development Center, Department of Microbiology, Immunology and Cell Biology. Morgantown, WV 26505, United States http://orcid.org/0000-0002-0008-7690 Wilks Angela * Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States http://orcid.org/0000-0002-4132-9887 Xue Fengtian * Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, Maryland 21201, United States Author Contributions FX and AW contributed to project conceptualization, supervision, and funding acquisition. LH and FX synthesized and characterized GaSal-2. KJ synthesized GaSal. WY and ADM performed CADD SILCS studies. GC purified HasAp and performed STD NMR experiments. AF purified HasAp, prepared 15 * Corresponding Author Angela Wilks awilks@rx.umaryland.edu Fengtian Xue fxue@rx.umaryland.edu Conflict of Interest FX and AW are co-founders of Galio Therapeutics LLC ADM is co-founder and CSO of SilcsBio LLC 08 8 2025 29 7 2025 11 8 498135 2287 2300 25 09 2025 02 10 2025 03 10 2025 03 10 2025 Multidrug-resistant Pseudomonas aeruginosa P. aeruginosa hasAp hasR P. aeruginosa hasR P. aeruginosa P. aeruginosa Graphical Abstract  Pseudomonas aeruginosa heme acquisition extracellular hemophore biofilms gallium complex pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access no pmc-prop-olf no pmc-prop-manuscript yes pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes ",
  "metadata": {
    "Title of this paper": "GaSal-2: A Water-Soluble Antipseudomonal Agent Targeting the Extracellular Hemophore HasAp",
    "Journal it was published in:": "ACS infectious diseases",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490196/"
  }
}